Unity Biotechnology Statistics

Total Valuation

UBX has a market cap or net worth of $16.19 million. The enterprise value is $17.50 million.

Market Cap	16.19M
Enterprise Value	17.50M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

UBX has 16.87 million shares outstanding. The number of shares has increased by 13.90% in one year.

Current Share Class	16.87M
Shares Outstanding	16.87M
Shares Change (YoY)	+13.90%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	0.80%
Owned by Institutions (%)	11.51%
Float	14.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.70
P/TBV Ratio	2.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.62, with a Debt / Equity ratio of 3.62.

Current Ratio	2.62
Quick Ratio	2.52
Debt / Equity	3.62
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -148.97% and return on invested capital (ROIC) is -41.66%.

Return on Equity (ROE)	-148.97%
Return on Assets (ROA)	-34.43%
Return on Invested Capital (ROIC)	-41.66%
Return on Capital Employed (ROCE)	-100.23%
Revenue Per Employee	n/a
Profits Per Employee	-$1.62M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.46% in the last 52 weeks. The beta is 1.30, so UBX's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-41.46%
50-Day Moving Average	1.83
200-Day Moving Average	1.49
Relative Strength Index (RSI)	26.07
Average Volume (20 Days)	217,731

Short Selling Information

The latest short interest is 639,936, so 3.79% of the outstanding shares have been sold short.

Short Interest	639,936
Short Previous Month	554,927
Short % of Shares Out	3.79%
Short % of Float	4.30%
Short Ratio (days to cover)	5.24

Income Statement

Revenue	n/a
Gross Profit	-13.01M
Operating Income	-28.47M
Pretax Income	-27.86M
Net Income	-25.99M
EBITDA	-27.60M
EBIT	-28.47M
Earnings Per Share (EPS)	-$1.54

Full Income Statement

Balance Sheet

The company has $23.23 million in cash and $23.54 million in debt, giving a net cash position of -$309,000 or -$0.02 per share.

Cash & Cash Equivalents	23.23M
Total Debt	23.54M
Net Cash	-309,000
Net Cash Per Share	-$0.02
Equity (Book Value)	6.49M
Book Value Per Share	0.39
Working Capital	15.01M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.87M
Capital Expenditures	n/a
Free Cash Flow	-20.87M
FCF Per Share	-$1.24

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.90%
Shareholder Yield	-13.90%
Earnings Yield	-151.18%
FCF Yield	-121.37%

Analyst Forecast

The average price target for UBX is $5.33, which is 455.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.33
Price Target Difference	455.15%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Oct 20, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1